Kristoffer Stewart
@journal-kristoffer.bsky.social
Clinical editor at BMJ Oncology & BMJ Immunology
Pharmacist turned editor
he/his
#ClinicalEditor #Oncology #Immunology
Pharmacist turned editor
he/his
#ClinicalEditor #Oncology #Immunology
Pinned
Homepage | BMJ Oncology
bmjoncology.bmj.com
Hi everyone! 👋
I'm new to #BSKY and want to connect with those working in the #oncology field. I'm the clinical editor for a new journal BMJ Oncology (bmjoncology.bmj.com).
I want to connect with clinicians interested in discussing meaningful, applicable advances that benefit human #health🩺
I'm new to #BSKY and want to connect with those working in the #oncology field. I'm the clinical editor for a new journal BMJ Oncology (bmjoncology.bmj.com).
I want to connect with clinicians interested in discussing meaningful, applicable advances that benefit human #health🩺
Cancer is a very stressful disease, not only physically but also psychologically. A meta-analysis now shows that patients who have to endure this stress alone are more likely to die than those who have a supportive social environment.
doi.org/10.1136/bmjo...
doi.org/10.1136/bmjo...
Impact of loneliness on cancer mortality: a systematic review and meta-analysis
Objective Loneliness and social isolation can have profound emotional and psychological impact on patients with cancer. Previous studies suggest loneliness may adversely impact cancer prognosis and su...
doi.org
November 5, 2025 at 3:02 PM
Excited to be at #esmo! Though there is so much on the agenda I don't know where to begin - suggestions are welcome!
@myesmo.bsky.social
@myesmo.bsky.social
October 17, 2025 at 9:45 AM
Excited to be at #esmo! Though there is so much on the agenda I don't know where to begin - suggestions are welcome!
@myesmo.bsky.social
@myesmo.bsky.social
Reposted by Kristoffer Stewart
✅ Highlights the urgent need for equity & global trial harmonization.
❓ Question to think: Should trial standards always reflect the best global care — or adapt to local realities?
#OncoEthics #GlobalOncology #ClinicalTrials #OncoTwitter #Medicalwatch
bmjoncology.bmj.com/content/4/1/...
❓ Question to think: Should trial standards always reflect the best global care — or adapt to local realities?
#OncoEthics #GlobalOncology #ClinicalTrials #OncoTwitter #Medicalwatch
bmjoncology.bmj.com/content/4/1/...
Inferior control arms in oncology trials in LMICs: contextualised or compromised?
In recent years, cancer drug randomised controlled trials (RCTs) have been criticised for employing a control arm treatment that is inferior or suboptimal to the existing standard of care.1 2 Using an...
bmjoncology.bmj.com
August 27, 2025 at 2:43 PM
✅ Highlights the urgent need for equity & global trial harmonization.
❓ Question to think: Should trial standards always reflect the best global care — or adapt to local realities?
#OncoEthics #GlobalOncology #ClinicalTrials #OncoTwitter #Medicalwatch
bmjoncology.bmj.com/content/4/1/...
❓ Question to think: Should trial standards always reflect the best global care — or adapt to local realities?
#OncoEthics #GlobalOncology #ClinicalTrials #OncoTwitter #Medicalwatch
bmjoncology.bmj.com/content/4/1/...
Really excited to see this paper live on BMJ Oncology!
The authors have provided a comprehensive overview of novel radiopharmaceuticals for molecular imaging of renal cell carcinoma🔬
bmjoncology.bmj.com/content/4/1/...
#radiation #kidneycancer #oncology
The authors have provided a comprehensive overview of novel radiopharmaceuticals for molecular imaging of renal cell carcinoma🔬
bmjoncology.bmj.com/content/4/1/...
#radiation #kidneycancer #oncology
Novel radiopharmaceuticals for molecular imaging of renal cell carcinoma
Conventional diagnostic strategies for imaging patients with renal cell carcinoma (RCC) have predominantly relied on ultrasonography, CT and MRI. However, a paradigm shift is underway with the emergen...
bmjoncology.bmj.com
August 18, 2025 at 8:55 AM
Really excited to see this paper live on BMJ Oncology!
The authors have provided a comprehensive overview of novel radiopharmaceuticals for molecular imaging of renal cell carcinoma🔬
bmjoncology.bmj.com/content/4/1/...
#radiation #kidneycancer #oncology
The authors have provided a comprehensive overview of novel radiopharmaceuticals for molecular imaging of renal cell carcinoma🔬
bmjoncology.bmj.com/content/4/1/...
#radiation #kidneycancer #oncology
Really excited to see this paper live on BMJ Oncology!
The authors have provided a comprehensive overview of the tumour-infiltrating lymphocyte therapy landscape, and their work will be a valuable resource for the field 🔬
bmjoncology.bmj.com/content/4/1/...
#immunotherapy #immunology #oncology
The authors have provided a comprehensive overview of the tumour-infiltrating lymphocyte therapy landscape, and their work will be a valuable resource for the field 🔬
bmjoncology.bmj.com/content/4/1/...
#immunotherapy #immunology #oncology
August 5, 2025 at 8:24 AM
Really excited to see this paper live on BMJ Oncology!
The authors have provided a comprehensive overview of the tumour-infiltrating lymphocyte therapy landscape, and their work will be a valuable resource for the field 🔬
bmjoncology.bmj.com/content/4/1/...
#immunotherapy #immunology #oncology
The authors have provided a comprehensive overview of the tumour-infiltrating lymphocyte therapy landscape, and their work will be a valuable resource for the field 🔬
bmjoncology.bmj.com/content/4/1/...
#immunotherapy #immunology #oncology
We're hiring a new clinical editor to join our team and support the launch of a new journal, BMJ Surgery
Clinical Editor - BMJ Surgery
£69,632 (pro-rata 0.4fte)
London, Hybrid
jobsearch.bmj.com/jobs/latest
If you want to know more email kstewart@bmj.com
Clinical Editor - BMJ Surgery
£69,632 (pro-rata 0.4fte)
London, Hybrid
jobsearch.bmj.com/jobs/latest
If you want to know more email kstewart@bmj.com
Jobs and careers with BMJ Group
Jobs and careers with BMJ Group -
jobsearch.bmj.com
July 19, 2025 at 8:39 AM
We're hiring a new clinical editor to join our team and support the launch of a new journal, BMJ Surgery
Clinical Editor - BMJ Surgery
£69,632 (pro-rata 0.4fte)
London, Hybrid
jobsearch.bmj.com/jobs/latest
If you want to know more email kstewart@bmj.com
Clinical Editor - BMJ Surgery
£69,632 (pro-rata 0.4fte)
London, Hybrid
jobsearch.bmj.com/jobs/latest
If you want to know more email kstewart@bmj.com
Reposted by Kristoffer Stewart
Significant gaps in testing for #lynchsyndrome #hereditarycancer risk, UK study finds @bmj.com
#cancerresearch #oncsky #openaccess
#cancerresearch #oncsky #openaccess
Mismatch in testing: a retrospective analysis of mismatch repair testing in endometrial cancer and Lynch syndrome diagnosis in multiple specialist centres in the UK and Ireland (March 2022–March 2023)
Objectives To assess the implementation of Lynch syndrome testing in endometrial cancer (EC) across the UK and Ireland, identify diagnostic gaps and evaluate adherence to the National Institute for He...
bmjoncology.bmj.com
June 10, 2025 at 8:31 PM
Significant gaps in testing for #lynchsyndrome #hereditarycancer risk, UK study finds @bmj.com
#cancerresearch #oncsky #openaccess
#cancerresearch #oncsky #openaccess
Can targeted therapies towards the hypoxia-inducible factor (HIF) pathway enhance the potency of current cancer treatments? This review explores the science:
bmjoncology.bmj.com/content/3/1/...
#cancer #hypoxia #oncology
bmjoncology.bmj.com/content/3/1/...
#cancer #hypoxia #oncology
Hypoxia-inducible factor in cancer: from pathway regulation to therapeutic opportunity
Cancer remains one of the most formidable challenges in modern medicine, due to its complex and dynamic nature, which demands innovative therapeutic approaches. One major challenge to cancer treatment...
bmjoncology.bmj.com
June 6, 2025 at 9:18 AM
Can targeted therapies towards the hypoxia-inducible factor (HIF) pathway enhance the potency of current cancer treatments? This review explores the science:
bmjoncology.bmj.com/content/3/1/...
#cancer #hypoxia #oncology
bmjoncology.bmj.com/content/3/1/...
#cancer #hypoxia #oncology
Reposted by Kristoffer Stewart
New pub on cancer accelerated approvals in which we find: 1) PMR statements often lack specificity on key study design elements and 2) less stringent specs in PMR statements are associated with on-time submission, potentially trading rigor for speed. bmjoncology.bmj.com/content/4/1/...
Specificity of Food and Drug Administration postmarketing requirements and associations with timely submissions and regulatory decisions for oncology accelerated approvals, 2011–2023: a cross-sectiona...
Objectives To assess the specificity of postmarketing requirement (PMR) statements and associations between PMR statement specificity and PMR study characteristics, timeliness and regulatory decisions...
bmjoncology.bmj.com
May 23, 2025 at 8:57 PM
New pub on cancer accelerated approvals in which we find: 1) PMR statements often lack specificity on key study design elements and 2) less stringent specs in PMR statements are associated with on-time submission, potentially trading rigor for speed. bmjoncology.bmj.com/content/4/1/...
I'm wondering if I can get some help with the kind people of @bsky.app. I'm trying to compile a list of key conferences across the broad field of #immunology - if you have any thoughts please reply or directly message.
All suggestions welcome!👍
All suggestions welcome!👍
April 25, 2025 at 1:31 PM
I'm wondering if I can get some help with the kind people of @bsky.app. I'm trying to compile a list of key conferences across the broad field of #immunology - if you have any thoughts please reply or directly message.
All suggestions welcome!👍
All suggestions welcome!👍
Reposted by Kristoffer Stewart
BMJ Oncology features research from OUCH members Dr. Roselle De Guzman & Dr. Joan Schiller on how pollutants contribute to cancer incidence and outcomes. Cleaner air isn't just an environmental issue; it's a public health necessity.
Read more: bmjoncology.bmj.com/content/4/1/...
#CancerResearch
Read more: bmjoncology.bmj.com/content/4/1/...
#CancerResearch
Air pollution and its impact on cancer incidence, cancer care and cancer outcomes
Air pollution is an under-recognised global health threat linked to an increased risk of cancers and is due primarily to the burning of fossil fuels. This review provides a high-level overview of the ...
bmjoncology.bmj.com
April 4, 2025 at 2:40 AM
BMJ Oncology features research from OUCH members Dr. Roselle De Guzman & Dr. Joan Schiller on how pollutants contribute to cancer incidence and outcomes. Cleaner air isn't just an environmental issue; it's a public health necessity.
Read more: bmjoncology.bmj.com/content/4/1/...
#CancerResearch
Read more: bmjoncology.bmj.com/content/4/1/...
#CancerResearch
Reposted by Kristoffer Stewart
Innovations in #clinical #education - great opportunity to listen to ways to maximise learning for students across #healthcare #crtitical
#thinking and #creative #arts. Don’t miss it 👇 @radchat.bsky.social @journal-kristoffer.bsky.social @yattsang.bsky.social @gerryhanna.bsky.social
#thinking and #creative #arts. Don’t miss it 👇 @radchat.bsky.social @journal-kristoffer.bsky.social @yattsang.bsky.social @gerryhanna.bsky.social
Join us on February 26th when Leo Arnold presents the next in our #CPD webinar series 'Perspectives on clinical education'. Scan the QR code to register #CPD #radiotherapy #RTT #radonc #radiationtherapy #clinical #education
February 12, 2025 at 12:08 PM
Innovations in #clinical #education - great opportunity to listen to ways to maximise learning for students across #healthcare #crtitical
#thinking and #creative #arts. Don’t miss it 👇 @radchat.bsky.social @journal-kristoffer.bsky.social @yattsang.bsky.social @gerryhanna.bsky.social
#thinking and #creative #arts. Don’t miss it 👇 @radchat.bsky.social @journal-kristoffer.bsky.social @yattsang.bsky.social @gerryhanna.bsky.social
Reposted by Kristoffer Stewart
Happy PM day to all who celebrate! PubMed, that is. BMJ Oncology is proud to announce that all our content is now available on PubMed! 🎉 🍾 🥂 @journal-kristoffer.bsky.social @mazer.us @eabhalynn.bsky.social @oncoalert.bsky.social
February 1, 2025 at 10:27 AM
Happy PM day to all who celebrate! PubMed, that is. BMJ Oncology is proud to announce that all our content is now available on PubMed! 🎉 🍾 🥂 @journal-kristoffer.bsky.social @mazer.us @eabhalynn.bsky.social @oncoalert.bsky.social
A study by Zhao et al. showed that since 1990, the incidence and deaths of early onset cancers have substantially increased globally🌍🌏🌍
Countries with a high-middle and middle Sociodemographic Index and individuals aged 40–49 years were particularly affected
bmjoncology.bmj.com/content/2/1/...
Countries with a high-middle and middle Sociodemographic Index and individuals aged 40–49 years were particularly affected
bmjoncology.bmj.com/content/2/1/...
Global trends in incidence, death, burden and risk factors of early-onset cancer from 1990 to 2019
Objective This study aimed to explore the global burden of early-onset cancer based on the Global Burden of Disease (GBD) 2019 study for 29 cancers worldwid.Methods and analysis Incidence, deaths, dis...
bmjoncology.bmj.com
December 3, 2024 at 2:53 PM
A study by Zhao et al. showed that since 1990, the incidence and deaths of early onset cancers have substantially increased globally🌍🌏🌍
Countries with a high-middle and middle Sociodemographic Index and individuals aged 40–49 years were particularly affected
bmjoncology.bmj.com/content/2/1/...
Countries with a high-middle and middle Sociodemographic Index and individuals aged 40–49 years were particularly affected
bmjoncology.bmj.com/content/2/1/...
I think this is great!
If you want @bsky.app to continue to grow then give the big publishing bodies an excuse to back this app - share research and click on research. #research #oncology
If you want @bsky.app to continue to grow then give the big publishing bodies an excuse to back this app - share research and click on research. #research #oncology
BLUESKY MEGA-THREAD
Altmetric is thrilled and also LITERALLY RELIEVED to officially announce:
We are now tracking research attention as it happens on Bluesky!
We have been picking up posts on the site since late Oct.
Our team is on Bluesky all day answering questions.
Let's get into it!
Altmetric is thrilled and also LITERALLY RELIEVED to officially announce:
We are now tracking research attention as it happens on Bluesky!
We have been picking up posts on the site since late Oct.
Our team is on Bluesky all day answering questions.
Let's get into it!
December 3, 2024 at 2:44 PM
This is a true testament to how I think this platform differs - I don't know this account, but just check out how wholesome it is as a concept 🥰
I look forward to following, committing to reading the book and
inevitably letting everyone down 😅
@oncologybookclub.bsky.social @bsky.app
I look forward to following, committing to reading the book and
inevitably letting everyone down 😅
@oncologybookclub.bsky.social @bsky.app
November 29, 2024 at 11:14 AM
This is a true testament to how I think this platform differs - I don't know this account, but just check out how wholesome it is as a concept 🥰
I look forward to following, committing to reading the book and
inevitably letting everyone down 😅
@oncologybookclub.bsky.social @bsky.app
I look forward to following, committing to reading the book and
inevitably letting everyone down 😅
@oncologybookclub.bsky.social @bsky.app
Flash backs to university when my friends who left their dissertation write-up and submission to the final minute and did better than me 😆
If you submit your grants last minute, you're in good company. For the 2005 NIH Pioneer grant, half of the applications were submitted in the last two days. The red bars indicate the awardees. One awardee submitted 8 minutes before the deadline.
bsky.app/profile/jere... @jeremymberg.bsky.social
bsky.app/profile/jere... @jeremymberg.bsky.social
November 28, 2024 at 3:25 PM
Flash backs to university when my friends who left their dissertation write-up and submission to the final minute and did better than me 😆
📣 Check out this recent study:
UK national observational cohort study investigating Tolerance of Anti-cancer Systemic Therapy in the Elderly: the TOASTIE study
From @drmarkbaxter.bsky.social and colleagues: bmjoncology.bmj.com/content/3/1/...
#cancer #chemotherapy
UK national observational cohort study investigating Tolerance of Anti-cancer Systemic Therapy in the Elderly: the TOASTIE study
From @drmarkbaxter.bsky.social and colleagues: bmjoncology.bmj.com/content/3/1/...
#cancer #chemotherapy
UK national observational cohort study investigating Tolerance of Anti-cancer Systemic Therapy in the Elderly: the TOASTIE study
Objective The Cancer and Aging Research Group (CARG) score was developed to predict severe chemotherapy-induced toxicity risk in older adults; validation study results have varied. The Tolerance of An...
bmjoncology.bmj.com
November 28, 2024 at 1:33 PM
📣 Check out this recent study:
UK national observational cohort study investigating Tolerance of Anti-cancer Systemic Therapy in the Elderly: the TOASTIE study
From @drmarkbaxter.bsky.social and colleagues: bmjoncology.bmj.com/content/3/1/...
#cancer #chemotherapy
UK national observational cohort study investigating Tolerance of Anti-cancer Systemic Therapy in the Elderly: the TOASTIE study
From @drmarkbaxter.bsky.social and colleagues: bmjoncology.bmj.com/content/3/1/...
#cancer #chemotherapy
Reposted by Kristoffer Stewart
We are working on a whole new set of courses on #palliativecare for BMJ Learning, starting with this one on pain management.
If you want to know more, please contact: @journal-kristoffer.bsky.social
If you want to know more, please contact: @journal-kristoffer.bsky.social
November 26, 2024 at 9:20 AM
We are working on a whole new set of courses on #palliativecare for BMJ Learning, starting with this one on pain management.
If you want to know more, please contact: @journal-kristoffer.bsky.social
If you want to know more, please contact: @journal-kristoffer.bsky.social
I clicked through into this special issue and nearly every article drew me in, such an interesting array of work.
Give it a click this Friday afternoon and treat yourself to a bit of insight! 💻📱
Well done to all involved 👏
Give it a click this Friday afternoon and treat yourself to a bit of insight! 💻📱
Well done to all involved 👏
We have added two new articles to our Special Issue on the Commercial Determinants today - led by @hannahpitt.bsky.social , and @ph-anna.bsky.social .
We now have 21 articles published in this special issue at @healthpromint.bsky.social with more to come! 👏 👏
academic.oup.com/heapro/issue...
We now have 21 articles published in this special issue at @healthpromint.bsky.social with more to come! 👏 👏
academic.oup.com/heapro/issue...
Volume 39 Issue 6 | Health Promotion International | Oxford Academic
Publishes papers on major themes and innovations in the health promotion field. The journal publishes contributions from sectors beyond health, and seeks to promote theoretical, methodological, and ac...
academic.oup.com
November 22, 2024 at 12:29 PM
I clicked through into this special issue and nearly every article drew me in, such an interesting array of work.
Give it a click this Friday afternoon and treat yourself to a bit of insight! 💻📱
Well done to all involved 👏
Give it a click this Friday afternoon and treat yourself to a bit of insight! 💻📱
Well done to all involved 👏
Are we overlooking cancer's hidden toxicities?
🧠Mental health strain
💰 Financial burdens
⏳ Logistical chaos
Should addressing these be as routine as managing the tumor itself?
#Oncology #CancerCare
Check out this paper by BMJ ONC's patient advocate Rick Bangs:
bmjoncology.bmj.com/content/3/1/...
🧠Mental health strain
💰 Financial burdens
⏳ Logistical chaos
Should addressing these be as routine as managing the tumor itself?
#Oncology #CancerCare
Check out this paper by BMJ ONC's patient advocate Rick Bangs:
bmjoncology.bmj.com/content/3/1/...
November 20, 2024 at 3:56 PM
Are we overlooking cancer's hidden toxicities?
🧠Mental health strain
💰 Financial burdens
⏳ Logistical chaos
Should addressing these be as routine as managing the tumor itself?
#Oncology #CancerCare
Check out this paper by BMJ ONC's patient advocate Rick Bangs:
bmjoncology.bmj.com/content/3/1/...
🧠Mental health strain
💰 Financial burdens
⏳ Logistical chaos
Should addressing these be as routine as managing the tumor itself?
#Oncology #CancerCare
Check out this paper by BMJ ONC's patient advocate Rick Bangs:
bmjoncology.bmj.com/content/3/1/...
Clinical endpoints (eg survival) measure real outcomes, but surrogate endpoints (eg tumor shrinkage) often fall short of predicting outcomes
Can misuse of surrogates in trials harm patients? Are we too reliant on surrogates?
bmjoncology.bmj.com/content/3/1/...
@vinayprasadmdmph.bsky.social #Oncology
Can misuse of surrogates in trials harm patients? Are we too reliant on surrogates?
bmjoncology.bmj.com/content/3/1/...
@vinayprasadmdmph.bsky.social #Oncology
Bedside implications of the use of surrogate endpoints in solid and haematological cancers: implications for our reliance on PFS, DFS, ORR, MRD and more
Clinical endpoints, such as overall survival, directly measure relevant outcomes. Surrogate endpoints, in contrast, are intermediate, stand-in measures of various tumour-related metrics and include tu...
bmjoncology.bmj.com
November 20, 2024 at 12:06 PM
Clinical endpoints (eg survival) measure real outcomes, but surrogate endpoints (eg tumor shrinkage) often fall short of predicting outcomes
Can misuse of surrogates in trials harm patients? Are we too reliant on surrogates?
bmjoncology.bmj.com/content/3/1/...
@vinayprasadmdmph.bsky.social #Oncology
Can misuse of surrogates in trials harm patients? Are we too reliant on surrogates?
bmjoncology.bmj.com/content/3/1/...
@vinayprasadmdmph.bsky.social #Oncology
Couldn't agree more!👏
The joy of not having to scroll past adverts, promoted content and boosted profiles on x!
I'm excited to dive deeper and connect with those excited about sharing their ideas, work and enthusiasm!
The joy of not having to scroll past adverts, promoted content and boosted profiles on x!
I'm excited to dive deeper and connect with those excited about sharing their ideas, work and enthusiasm!
It’s fantastic to find so many friends already here. As others have noted, this feels like the early days of science twitter (RIP).
November 20, 2024 at 11:26 AM
Couldn't agree more!👏
The joy of not having to scroll past adverts, promoted content and boosted profiles on x!
I'm excited to dive deeper and connect with those excited about sharing their ideas, work and enthusiasm!
The joy of not having to scroll past adverts, promoted content and boosted profiles on x!
I'm excited to dive deeper and connect with those excited about sharing their ideas, work and enthusiasm!
Hi everyone! 👋
I'm new to #BSKY and want to connect with those working in the #oncology field. I'm the clinical editor for a new journal BMJ Oncology (bmjoncology.bmj.com).
I want to connect with clinicians interested in discussing meaningful, applicable advances that benefit human #health🩺
I'm new to #BSKY and want to connect with those working in the #oncology field. I'm the clinical editor for a new journal BMJ Oncology (bmjoncology.bmj.com).
I want to connect with clinicians interested in discussing meaningful, applicable advances that benefit human #health🩺
Homepage | BMJ Oncology
bmjoncology.bmj.com
November 20, 2024 at 9:38 AM
Hi everyone! 👋
I'm new to #BSKY and want to connect with those working in the #oncology field. I'm the clinical editor for a new journal BMJ Oncology (bmjoncology.bmj.com).
I want to connect with clinicians interested in discussing meaningful, applicable advances that benefit human #health🩺
I'm new to #BSKY and want to connect with those working in the #oncology field. I'm the clinical editor for a new journal BMJ Oncology (bmjoncology.bmj.com).
I want to connect with clinicians interested in discussing meaningful, applicable advances that benefit human #health🩺